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Abstract
Background: In a cross-sectional community based study, as part of a randomised controlled trial
of eradication of Helicobacter pylori infection, the association between blood pressure and
symptoms of gastro-oesophageal reflux was examined.
Methods: Linear regression was used to examine the association between systolic and diastolic
blood pressure and the frequency of heartburn and acid regurgitation in 4,902 of 10,537
participants aged 20–59 years.
Results: In multivariable analyses, adjusted mean systolic blood pressure was 4.2 (95% confidence
interval 1.5 to 7.0) mm Hg lower in participants with daily acid regurgitation compared to those
with less frequent symptoms. Similarly, for diastolic blood pressure, a reduction of 2.1 (0.0 to 4.3)
mm Hg wasobserved.
Conclusion: People who experience daily symptoms of gastro-oesophageal reflux have lower
blood pressure than people with less frequent or no symptoms. It is possible that factors influencing
nitric oxide concentrations both at the lower oesophageal sphincter and within the vasculature may
be involved. This hypothesis requires confirmation.
Trials registration number: ISRCTN44816925
Background
In 2003 we reported reduced stroke mortality among
patients with oesophageal columnar epithelium (Barrett's
oesophagus), with cerebrovascular deaths in patients with
specialised intestinal metaplasia of the oesophagus being
half that of the general population [1]. Subsequently, a
postmarketing surveillance study of 18,000 patients on
omeprazole in the United Kingdom has not shown any
reduction in stroke mortality in these patients compared
to the general population [2] but this drug is often pre-
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scribed for upper gastrointestinal conditions other than
gastro-oesophageal reflux and Barrett's oesophagus. We
hypothesised that the association we observed may be due
to individuals with reduced lower oesophageal sphincter
(LOS) pressure, (a risk factor for gastro-oesophageal reflux
and Barrett's oesophagus) also having low vascular tone
and blood pressure, resulting in reduced stroke risk. To
investigate this, we examined whether blood pressure is
associated with symptoms of gastro-oesophageal reflux.
Methods
From 1996 to 1998, 10,537 individuals, aged 20–59
years, registered with seven general practices in Southwest
England were enrolled in a community based randomised
controlled trial of eradication of Helicobacter pylori (H.
pylori). The trial obtained ethics approval from Frenchay
Hospital LREC (reference number: 95/83 20/01/1996)
and participants provided written informed consent. Par-
ticipants provided information on the frequency of dys-
peptic symptoms experienced in the previous three
months, including heartburn ("a burning or ache behind
the sternum not due to heart trouble") and acid regurgita-
tion ("a very sour or acid tasting fluid at the back of the
throat") using a validated questionnaire [3]. In addition,
blood pressure, height, and weight were measured and
data on antihypertensive medication, smoking history,
alcohol and coffee consumption, and adult social class
(derived from current occupation) were collected. The
current analysis is based on all participants who tested
positive for H. pylori infection (n = 1,634) and a computer
generated random sample of H. pylori negative partici-
pants (n = 3,268) to give a H. pylori negative to positive
ratio of 2:1
Linear regression was used to examine the association
between systolic and diastolic blood pressure and the fre-
quency of heartburn and acid regurgitation (daily vs. less
frequent). Analyses took account of the clustered nature of
the data (by general practice), and the increased sampling
of H. pylori positive participants – 33% of participants
included in the database, but 15.5% of all participants
screened – was dealt with by applying weights that were
proportional to the inverse of the sampling fractions. Ini-
tial analyses were adjusted for age (years) and sex, while
in fully-adjusted analyses we additionally controlled for
body mass index (weight(kg)/height2(m), smoking habit
(never; ex-smoker; current smoker, <20 a day; current
smoker = 20 a day), weekly alcohol intake in units (none;
<10; 10–19; = 20), daily coffee consumption in cups
(none; 1–4; = 5) and adult social class (manual, non-man-
ual). Similar analyses were conducted to examine whether
the frequency of the occurrence of other dyspeptic symp-
toms (epigastric pain/discomfort, nausea, wind and
belching) was associated with blood pressure. Since age-
adjusted results were similar for the total sample and the
4,227 (86.2%) individuals with data available on all con-
founders we report only the latter here. Analyses were car-
ried out using Stata 7.0 (College Station, Texas, USA).
Results
One hundred and seven (2.5%) and 66 (1.6%) of the
4,227 participants with complete data experienced daily
heartburn or acid regurgitation respectively. Participants
experiencing either daily acid regurgitation or heartburn
symptoms were heavier, and smoked more cigarettes than
people with less frequent symptoms, while those with
daily heartburn consumed more alcohol and were more
likely to come from manual social class (Table 1). In age
and sex-adjusted analyses, restricted to individuals not
receiving antihypertensive medication (258 excluded),
participants with daily acid regurgitation had lower mean
systolic and diastolic blood pressure than individuals who
had less frequent or no acid regurgitation (Table 2). Con-
trolling for potential confounders strengthened these
associations. There was no association between daily
heartburn or the other dyspeptic symptoms and blood
pressure.
Discussion
We found an inverse association between experiencing
daily acid regurgitation and blood pressure. This was a
large, population based study, whose participants were
representative of the total sample. A wide age range of
both sexes were studied producing novel findings. Weak-
nesses, however, include the fact the study was symptom
based with no direct information regarding the underly-
ing endoscopic diagnosis. Some researchers suggest that
for heartburn a more complete 'word picture' than we
used is required to avoid misreporting this symptom [4].
Misclassification may therefore have contributed to the
weak relationship seen between blood pressure and heart-
burn. Moreover, as few participants in our study had daily
reflux symptoms, our results need to be viewed as prelim-
inary. However, there are several emerging strands of evi-
dence to support a causal relationship between gastro-
oesophageal reflux and low blood pressure. Firstly, this
finding is consistent with our previous observation of
lower stroke mortality in patients with Barrett's oesopha-
gus in a separate cohort from Northern Ireland [1]. Sec-
ondly, patients with gastro-oesophageal reflux disease
have been shown to have decreased sympathetic function,
with blunting of blood pressure responses to stress [5].
Thirdly, recent research into nitric oxide (NO) provides a
mechanistic link between gastro-oesophageal reflux and
low blood pressure. NO functions as the major non-
adrenergic non-cholinergic neurotransmitter in the auto-
nomic nervous system [6] and NO-mediated action
appears to be crucial in governing LOS pressure [7].
Patients with gastro-oesophageal reflux have elevated lev-
els of serum nitrate compared to controls [8] and infusionBMC Gastroenterology 2008, 8:10 http://www.biomedcentral.com/1471-230X/8/10
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of a NO synthase blocker has been seen to induce both
raised resting LOS tone and, in keeping with the well
known vasodilatory effects of NO, raised blood pressure
[9].
Conclusion
We suggest that factors influencing the endogenous pro-
duction of NO underlie the observed association between
symptoms of gastro-oesophageal reflux and blood pres-
sure. Confirmation of these findings, and further investi-
gation of the pathophysiological role that NO may play in
gastro-oesophageal reflux, and possibly Barrett's oesopha-
gus, are warranted.
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Table 1: Characteristics of participants with and without acid regurgitation or heartburn
Acid regurgitation, n (%) Heartburn, n (%)
No Yes No Yes
All participants 4161 (98.4) 66 (1.6) 4120 (97.5) 107 (2.5)
Males 1985 (47.7) 23 (36.5) 1952 (47.4) 57 (53.3)
Mean age (SD) 45.6 (8.9) 45.4 (9.3) 45.5 (9.0) 47.5 (8.5)
Receiving antihypertensives 255 (6.1) 3 (4.6) 255 (6.1) 3 (2.8)
Mean BMI (SD) 26.7 (4.4) 28.8 (4.6) 26.8 (4.4) 28.9 (5.2)
Cigarettes
Never 2204 (53.0) 31 (47.0) 2183 (53.0) 52 (48.6)
Ever 987 (23.7) 8 (12.1) 976 (23.7) 19 (17.8)
Current, <20/day 597 (14.4) 8 (12.1) 589 (14.3) 16 (15.0)
Current, = 20/day 373 (9.0) 19 (28.8) 372 (9.0) 20 (18.7)
Alcohol (units/wk)
None 659 (15.8) 20 (30.3) 651 (15.8) 28 (26.2)
1–9 1966 (47.2) 26 (39.4) 1955 (47.4) 37 (34.6)
10–19 883 (21.2) 10 (15.2) 877 (21.3) 16 (15.0)
≥ 20 653 (15.7) 10 (15.2) 637 (15.5) 26 (24.3)
Coffee (cups/day)
None 801 (19.2) 20 (30.3) 792 (19.2) 29 (27.1)
1–4 2209 (53.1) 28 (42.4) 2182 (53.0) 55 (51.4)
≥ 5 1151 (27.7) 18 (27.3) 1146 (27.8) 23 (21.5)
Non- manual social class 2667 (64.1) 44 (66.7) 2653 (64.4) 58 (54.2)
Mean systolic BP (SD) 119.8 (21.7) 119.2 (19.4) 119.8 (21.8) 121.0 (16.2)
Mean diastolic BP (SD) 75.6 (19.2) 75.1 (10.6) 75.6 (19.3) 76.4 (12.0)
Data shown relate to 4227 participants with complete data
Table 2: Association between blood pressure and frequency of acid regurgitation and heartburn
Symptom, frequency n1 Mean difference in systolic blood pressure (mm Hg) (95% 
CI), p
Mean difference in diastolic blood pressure (mm Hg) 
(95% CI), p
Age and sex adjusted Fully-adjusted2 Age and sex adjusted Fully-adjusted2
Acid regurgitation
Daily 63 -2.5 (-4.2 to -0.8), 0.012 -4.2 (-7.0 to -1.5), 0.009 -0.9 (-2.9 to 1.2), 0.34 -2.1 (-4.3 to 0.0), 0.053
Less frequently 3906 1.00 (reference group) 1.00 1.00 1.00
Heartburn
Daily 104 1.7 (-3.7 to 7.1), 0.48 -0.5 (-6.8 to 5.8), 0.85 -0.6 (-1.3 to 2.5), 0.46 -0.9 (-2.8 to 1.1), 0.32
Less frequently 3865 1.00 1.00 1.00 1.00
1 Number of participants for whom full data available
2 Adjustment for age, sex, BMI, antihypertensive medication, smoking, coffee and alcohol intake, and social classPublish with BioMed Central    and   every 
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